Axa
LRCX icon

Axa’s Lam Research LRCX Stock Holding History

Axa’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$295K Hold
1,380
– – 0.12% 65
2025
Q4 		$236K Buy
+1,380
New +$215K 0.11% 71
2025
Q3 		– Sell
-793,787
Closed -$77.3M – 632
2025
Q2 		$77.3M Buy
793,787
+163,970
+26% +$13M 0.22% 98
2025
Q1 		$45.8M Buy
629,817
+77,585
+14% +$6.11M 0.15% 141
2024
Q4 		$39.9M Buy
552,232
+168,102
+44% +$12.8M 0.12% 165
2024
Q3 		$3.13M Sell
384,130
-38,170
-9% -$3.32M 0.01% 659
2024
Q2 		$45M Buy
422,300
+51,550
+14% +$4.94M 0.13% 159
2024
Q1 		$36M Sell
370,750
-22,210
-6% -$1.95M 0.11% 188
2023
Q4 		$30.8M Sell
392,960
-565,970
-59% -$38.6M 0.1% 208
2023
Q3 		$60.1M Sell
958,930
-16,520
-2% -$1.09M 0.21% 113
2023
Q2 		$62.7M Sell
975,450
-145,240
-13% -$8.19M 0.21% 116
2023
Q1 		$59.4M Buy
1,120,690
+690,300
+160% +$33.9M 0.2% 124
2022
Q4 		$18.1M Sell
430,390
-76,520
-15% -$3.2M 0.07% 322
2022
Q3 		$18.6M Buy
506,910
+16,770
+3% +$747K 0.07% 297
2022
Q2 		$20.9M Buy
490,140
+14,800
+3% +$705K 0.08% 286
2022
Q1 		$25.6M Buy
475,340
+190,720
+67% +$11.1M 0.07% 304
2021
Q4 		$20.5M Sell
284,620
-17,920
-6% -$1.12M 0.05% 352
2021
Q3 		$17.2M Sell
302,540
-109,100
-27% -$6.64M 0.05% 368
2021
Q2 		$26.8M Sell
411,640
-285,670
-41% -$18M 0.08% 291
2021
Q1 		$41.5M Buy
697,310
+120,390
+21% +$6.56M 0.13% 208
2020
Q4 		$27.2M Buy
576,920
+438,010
+315% +$18.4M 0.09% 257
2020
Q3 		$4.61M Sell
138,910
-456,340
-77% -$15.7M 0.02% 646
2020
Q2 		$19.3M Sell
595,250
-811,710
-58% -$22.1M 0.08% 272
2020
Q1 		$33.8M Buy
1,406,960
+536,730
+62% +$15.5M 0.17% 145
2019
Q4 		$25.4M Buy
870,230
+744,150
+590% +$19.8M 0.1% 243
2019
Q3 		$2.91M Sell
126,080
-33,580
-21% -$705K 0.01% 789
2019
Q2 		$3M Buy
159,660
+5,230
+3% +$99.2K 0.01% 784
2019
Q1 		$2.76M Sell
154,430
-98,220
-39% -$1.64M 0.01% 787
2018
Q4 		$3.44M Sell
252,650
-719,230
-74% -$10.3M 0.02% 698
2018
Q3 		$14.7M Sell
971,880
-215,000
-18% -$3.67M 0.05% 375
2018
Q2 		$20.5M Sell
1,186,880
-1,462,020
-55% -$28.2M 0.08% 280
2018
Q1 		$53.8M Sell
2,648,900
-333,000
-11% -$6.6M 0.21% 128
2017
Q4 		$54.9M Sell
2,981,900
-227,730
-7% -$4.47M 0.22% 136
2017
Q3 		$59.4M Sell
3,209,630
-928,300
-22% -$15.1M 0.26% 107
2017
Q2 		$58.5M Buy
4,137,930
+2,699,000
+188% +$39.6M 0.27% 104
2017
Q1 		$18.5M Sell
1,438,930
-1,213,070
-46% -$14.3M 0.08% 284
2016
Q4 		$28M Sell
2,652,000
-302,000
-10% -$3.07M 0.13% 204
2016
Q3 		$28M Buy
2,954,000
+1,766,000
+149% +$16.1M 0.12% 212
2016
Q2 		$9.99M Sell
1,188,000
-1,249,000
-51% -$10M 0.04% 392
2016
Q1 		$20.1M Buy
2,437,000
+1,711,000
+236% +$12.4M 0.09% 262
2015
Q4 		$5.77M Sell
726,000
-163,000
-18% -$1.23M 0.03% 525
2015
Q3 		$5.81M Hold
889,000
– – 0.02% 530
2015
Q2 		$7.23M Sell
889,000
-5,095,560
-85% -$40M 0.03% 486
2015
Q1 		$42M Sell
5,984,560
-145,240
-2% -$1.15M 0.17% 158
2014
Q4 		$48.6M Sell
6,129,800
-30,000
-0.5% -$233K 0.2% 146
2014
Q3 		$46M Buy
6,159,800
+411,400
+7% +$2.93M 0.2% 151
2014
Q2 		$38.8M Buy
5,748,400
+3,615,400
+169% +$21.6M 0.16% 173
2014
Q1 		$11.7M Buy
2,133,000
+556,000
+35% +$2.95M 0.05% 348
2013
Q4 		$8.59M Buy
1,577,000
+845,000
+115% +$4.45M 0.04% 409
2013
Q3 		$3.75M Hold
732,000
– – 0.02% 580
2013
Q2 		$3.25M Buy
+732,000
New +$3.31M 0.02% 588

Other funds holding LRCX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Axa's LRCX Position: Q1 2026 in Review

Axa held its Lam Research (LRCX) position steady in Q1 2026 at 1,380 shares worth $295K. The position accounts for 0.12% of the portfolio, ranked #65.

Axa first reported a position in LRCX in Q2 2013 and has held it in 51 quarters since. The position peaked at $77.3M in Q2 2025. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Axa held 1,380 shares of Lam Research worth $295K as of Q1 2026.
  • Axa left its Lam Research share count unchanged in Q1 2026.
  • Lam Research made up 0.12% of Axa's portfolio in Q1 2026, its #65 holding.
  • Axa first reported a position in Lam Research in Q2 2013 and has held it in 51 quarters since.
  • Axa's Lam Research position peaked at $77.3M in Q2 2025.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Axa's 13F filing for Q1 2026, filed 15 May 2026.